Subjects
This prospective, randomized, controlled study included 41 patients diagnosed with De Quervain tenosynovitis, which had been ongoing for more than 4 weeks, and who were admitted to ………………………………………between May 2019 and March 2020. The patients were diagnosed clinically using the Finkelstein test, in which the patient flexes the thumb and wraps the fingers over thumb, then the physician stabilizes the forearm and ulnarly deviates the wrist. The presence of pain over the abductor pollicis longus and extensor pollicis brevis tendons is accepted as positive test result. Patients were excluded from the study if they had chronic widespread or local musculoskeletal pain due to rheumatological diseases (i.e., fibromyalgia, rheumatoid arthritis), neurological diseases (i.e., multiple sclerosis, cervical discopathy or plexopathy), trauma or surgery to the related region (wrist, elbow or hand), or were aged <18 years or >65 years. From the total 41 patients initially enrolled, 2 did not wish to participate in the study, 2 did not complete the treatment sessions and 1 patient did not attend the evaluations at 1 month and 1 year after the end of the therapy. Final evaluation was made of a total of 36 patients (NT group:18; control group:18). Approval for the study was granted by the Ethics Committee of ……………………………………… Clinical Trials Registration was approved (NCT04384536). Informed consent was obtained from all the study participants.